ConductScience.org, home

Paper6496458

Treatment of polycythemia vera with hydroxyurea.

Donovan PB and 9 others. Am J Hematol, 1984. Cited by 99 papers, by iCite.

Cite this record

ConductScience Library. Treatment of polycythemia vera with hydroxyurea. Papers, record 6496458. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6496458

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Treatment of polycythemia vera with hydroxyurea.
PubMed
Journal
Am J Hematol
PubMed
Year
1984
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
99
iCite
Relative citation ratio, by iCite
3.15
iCite
Revised in PubMed
2019-08-21
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Donovan PBP B
2Kaplan MEM E
3Goldberg JDJ D
4Tatarsky II
5Najean YY
6Silberstein EBE B
7Knospe WHW H
8Laszlo JJ
9Mack KK
10Berk PDP D

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
HydroxyureaMajor topic
Polycythemia VeraMajor topic
Acute Disease
Aged
Bone Marrow
Female
Humans
Leukemia
Leukopenia
Male
Middle Aged
Thrombocytopenia
Thrombosis

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
CA-10728NCI NIH HHSUnited StatesR10CA010728PubMed and NIHNIH RePORTER
U10CA010728NIHNIH RePORTER

Download CSV of grants

Cited by13

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 99 citations.

PMIDTitleJournalYearIn PapersSource
42866221Monolayer WX2 (X = S, Se) as a drug delivery carrier for anticancer drugs hydroxyurea and nitrosourea: a first-principles study.Nanoscale Adv2026https://conductscience.org/library/papers/42866221PubMed
42275537A dynamic prognostic model for polycythemia vera long-term outcomes in patients treated with ruxolitinib.Blood Adv2026https://conductscience.org/library/papers/42275537PubMed
37705988Investigation of the adsorption behavior of the anti-cancer drug hydroxyurea on the graphene, BN, AlN, and GaN nanosheets and their doped structures via DFT and COSMO calculations.RSC Adv2023https://conductscience.org/library/papers/37705988PubMed
34480106Polycythemia vera: historical oversights, diagnostic details, and therapeutic views.Leukemia2021https://conductscience.org/library/papers/34480106PubMed
28304249Diagnosis and Management of Polycythemia Vera in a Ferret (Mustela putorius furo).Comp Med2016https://conductscience.org/library/papers/28304249PubMed
26366626Hydroxyurea therapy for sickle cell anemia.Expert Opin Drug Saf2015https://conductscience.org/library/papers/26366626PubMed
22102708Decrease in JAK2 V617F allele burden is not a prerequisite to clinical response in patients with polycythemia vera.Haematologica2012https://conductscience.org/library/papers/22102708PubMed
19009241Phase II open label trial of imatinib in polycythemia rubra vera.Int J Hematol2008https://conductscience.org/library/papers/19009241PubMed
8018766A prospective comparison between treatment with phlebotomy alone and with interferon-alpha in patients with polycythemia vera.Ann Hematol1994https://conductscience.org/library/papers/8018766PubMed
7548329Circulating hematopoietic progenitor cells in polycythemia vera: the in vivo effect of hydroxyurea.Ann Hematol1995https://conductscience.org/library/papers/7548329PubMed
7483176Polycythemia vera--a climatological disease.Trans Am Clin Climatol Assoc1995https://conductscience.org/library/papers/7483176PubMed
2597774Polycythemia vera. A clinical study of 141 patients.Blut1989https://conductscience.org/library/papers/2597774PubMed
1932299Interferon alpha-2b in the long-term treatment of essential thrombocythemia.Ann Hematol1991https://conductscience.org/library/papers/1932299PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6496458

GET https://conductscience.org/api/papers/v1/6496458/authors